$92.08
0.64% today
Nasdaq, Feb 28, 05:18 pm CET
ISIN
US5165441032
Symbol
LNTH

Lantheus Holdings Inc Stock price

$91.49
-6.82 6.94% 1M
-17.66 16.18% 6M
+2.03 2.27% YTD
+23.23 34.03% 1Y
+43.67 91.32% 3Y
+75.85 484.97% 5Y
+84.72 1,251.40% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-1.76 1.89%
ISIN
US5165441032
Symbol
LNTH
Sector

Key metrics

Market capitalization $6.36b
Enterprise Value $6.07b
P/E (TTM) P/E ratio 20.92
EV/FCF (TTM) EV/FCF 12.37
EV/Sales (TTM) EV/Sales 3.96
P/S ratio (TTM) P/S ratio 4.15
P/B ratio (TTM) P/B ratio 5.96
Revenue growth (TTM) Revenue growth 18.32%
Revenue (TTM) Revenue $1.53b
EBIT (operating result TTM) EBIT $445.87m
Free Cash Flow (TTM) Free Cash Flow $490.79m
Cash position $912.81m
EPS (TTM) EPS $4.37
P/E forward 16.57
P/S forward 3.95
EV/Sales forward 3.77
Short interest 13.55%
Show more

Is Lantheus Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Lantheus Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Lantheus Holdings Inc forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Lantheus Holdings Inc forecast:

Buy
92%
Hold
8%

Financial data from Lantheus Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,534 1,534
18% 18%
100%
- Direct Costs 546 546
22% 22%
36%
988 988
17% 17%
64%
- Selling and Administrative Expenses 310 310
43% 43%
20%
- Research and Development Expense 168 168
116% 116%
11%
510 510
8% 8%
33%
- Depreciation and Amortization 65 65
8% 8%
4%
EBIT (Operating Income) EBIT 446 446
10% 10%
29%
Net Profit 312 312
4% 4%
20%

In millions USD.

Don't miss a Thing! We will send you all news about Lantheus Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lantheus Holdings Inc Stock News

Neutral
The Motley Fool
one day ago
Lantheus Holdings (LNTH -1.07%) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic transactions.
Neutral
Seeking Alpha
2 days ago
Lantheus Holdings, Inc. (NASDAQ:LNTH ) Q4 2024 - Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Mark Kinarney - VP of IR Brian Markison - CEO Paul Blanchfield - President Bob Marshall - CFO Amanda Morgan - Chief Commercial Officer Conference Call Participants Roanna Ruiz - Leerink Partners Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities ...
Positive
The Motley Fool
3 days ago
Explore the exciting world of Lantheus Holdings (LNTH 1.39%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
More Lantheus Holdings Inc News

Company Profile

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Head office United States
CEO Brian Markison
Employees 808
Founded 1956
Website www.lantheus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today